Protalix share price logo

Protalix

AMEX: PLX

$2.74

-0.06

(-2.14%)

as on

Protalix Stock Performance

as on September 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.73
    $2.81
    downward going graph

    0.36%

    Downside

    2.55%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.60
    $3.19
    downward going graph

    41.61%

    Downside

    16.42%

    Upside

    downward going graph

Protalix share price movements today

Previous Close
$2.80
Open
$2.78
Volume
410.5K
Market Cap
$228.8M
Day's Low - High
$2.73 - $2.81
52 Week Low - High
$1.60 - $3.19

Protalix Historical Returns

1 Month Return
+ 16.18 %
3 Month Return
+ 25 %
1 Year Return
+ 35.92 %
3 Year Return
+ 68.67 %
5 Year Return
+ 113.74 %

Protalix Stock Fundamentals & Key Indicators

Check Protalix market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$228.8M

EPS (TTM)

0.241

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

22.41%

PE Ratio (TTM)

11.78

Industry PE ratio

-2.56

PEG Ratio

-0.019169219991457053

EBITDA

26.3M

Revenue (TTM)

80.6M

Profit Margin

69.20%

Return On Equity TTM

31.61%

Protalix Stock Valuation

Track how Protalix P/E has moved over time to understand its valuation trends.

Protalix in the last 5 years

  • Overview

  • Trends

Lowest (-21.40x)

December 31, 2025

Today (-21.40x)

December 31, 2025

Industry (-2.56x)

December 31, 2025

Highest (46.53x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -21.40x

Protalix vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Protalix with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Protalix image
Protalix
Buy$228.8M113.74%11.7869.20%0.00%
Moderna image
Moderna
Neutral$72.9B-57.66%-22.88-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$-180.48%29.7386.04%0.00%
Regeneron image
Regeneron
Buy$82.2B25.5%19.284.86%0.46%

Stock Returns calculator for Protalix Stock including INR - Dollar returns

The Protalix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Protalix investment value today

Current value as on today

₹1,43,749

Returns

₹43,749

(+43.75%)

Returns from Protalix Stock

₹33,010 (+33.01%)

Dollar Impact

₹10,739 (+10.74%)

Analyst Recommendation on Protalix Stock

Based on 1 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Protalix. Average target price of $11

Protalix Share Price Target

Get share price movements and forecasts by analysts on Protalix.

What analysts predicted

75.09%UPSIDE

Target Price

$11

Current Price

$2.74

Analyzed by

1 Analysts

Target

$11.00

Protalix target price $11, a slight upside of 75.09% compared to current price of $2.74. According to 1 analysts rating.

Indian Investors' Interest in Protalix Stock

Search interest for Protalix Stock has increased by 131% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:131% versus previous 30 day period

Protalix Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
3
13
17
18
10
15
17
9
33
19
Gross Profit
1
4
9
14
1
9
9
4
29
12
Operating Income
-4
-2
3
7
-4
1
2
-4
21
4
EBITDA
-4
-1
4
7
-3
1
2
-4
21
5
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-2
3
7
-3
0
2
-4
21
4
Income Tax Expense
0
0
0
0
0
0
0
0
2
1
Net Income
-4
-2
3
6
-3
0
2
-5
18
3
Net Profit Margin
30.58%
29.82%
53.37%
78.67%
19.11%
62.51%
53.37%
49.36%
87.77%
60.99%

Protalix Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
21
34
54
62
38
47
65
53
52
Gross Profit
5
24
43
52
22
28
42
29
25
Operating Income
-34
-19
-10
2
-20
-13
10
3
-5
EBITDA
-71
-17
-8
4
-18
-10
12
6
-2
Interest Expense
9
7
7
9
7
2
3
1
1
Depreciation
1
1
1
1
1
1
1
1
1
Income Before Tax
-83
-26
-18
-6
-27
-14
8
4
-5
Income Tax Expense
-
-
-
-
-
0
0
1
0
Net Income
-83
-26
-18
-6
-27
-14
8
2
-6
Net Profit Margin
27.74%
72.83%
80.08%
82.71%
57.37%
58.87%
64.91%
54.46%
47.85%

Protalix Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-4
-2
3
6
-3
0
2
-5
18
3
Operating Cash Flow
4
-3
4
3
-5
-5
-3
2
22
-10
Investing Cash Flow
0
0
20
-15
0
0
0
-1
4
-3
Financing Cash Flow
-
-
-20
3
5
4
-
0
0
-
Change in Cash
3
-3
4
-7
0
-1
-4
1
26
-13

Protalix Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-85
-26
-18
-6
-27
-14
8
2
-6
Operating Cash Flow
-9
-7
-19
-26
-10
-25
-1
8
-11
Investing Cash Flow
-1
0
0
-19
18
-5
-16
4
-2
Financing Cash Flow
-1
-4
-
46
12
8
24
-16
9
Change in Cash
-12
-13
-20
0
20
-21
6
-3
-4

Mutual Funds that own Protalix Stock

Check out the Mutual Funds with significant holdings in Protalix.

Funds
Holdings
Shares Held
Fidelity Salem Street Trust
0.962647%
775621
VANGUARD SCOTTSDALE FUNDS
0.530759%
427642
TIAA-CREF Funds
0.423482%
341207
Bridgeway Funds, Inc.
0.223403%
180000
SCHWAB CAPITAL TRUST
0.197725%
159311
See all

Global Institutional Holdings in Protalix

Funds
Holdings
iShares
3.54%
Fidelity Salem Street Trust
0.96%
Vanguard
0.63%
VANGUARD SCOTTSDALE FUNDS
0.53%
Dimensional
0.49%
See all

Insights on Protalix

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, PLX stock has moved up by 16.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 82.1% return, outperforming this stock by 13.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 603.7% return, outperforming this stock by 567.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 18.31M → 3.77M (in $), with an average decrease of 79.4% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 33.74M → 19.89M (in $), with an average decrease of 41.1% per quarter

About Protalix

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company provides Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. Protalix BioTherapeutics, Inc. has strategic partnership with Secarna Pharmaceuticals GmbH & Co KG. The company is headquartered in Hackensack. New Jersey.
OrganisationProtalix
Headquarters2 University Plaza, Hackensack, NJ, 07601, US
IndustryBiotechnology
CEODror Bashan
E-voting on sharesClick here to vote

Key Management of Protalix

Name

Title

Mr. Dror Bashan

President, CEO & Director

Mr. Gilad Mamlok

Senior VP, CFO Treasurer & Secretary

Mr. Yaron Naos B.Sc., MBA

SVP & COO

Ms. Yael Fellous

Vice President of Human Resources

FAQs

What is Protalix share price today?

Protalix share price today is $2.74 as on at the close of the market. Protalix share today touched a day high of $2.81 and a low of $2.73.

What is the 52 week high and 52 week low for Protalix share?

Protalix share touched a 52 week high of $3.19 on and a 52 week low of $1.60 on . Protalix stock price today i.e. is closed at $2.74,which is 14.11% down from its 52 week high and 71.25% up from its 52 week low.

What is Protalix's market capitalisation today?

Protalix market capitalisation is $0.00T as on .

How to invest in Protalix Stock (PLX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Protalix on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protalix Shares that will get you 0.5474 shares as per Protalix share price of $2.74 per share as on September 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Protalix Stock (PLX) from India?

Indian investors can start investing in Protalix (PLX) shares with as little as ₹95.945 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.45 in Protalix stock (as per the Rupee-Dollar exchange rate as on ). Based on Protalix share’s latest price of $2.74 as on September 25, 2026 at 1:29 am IST, you will get 3.6496 shares of Protalix. Learn more about fractional shares .

What are the returns that Protalix has given to Indian investors in the last 5 years?

Protalix stock has given 113.74% share price returns and 29.8% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?